Literature DB >> 25391611

Risk factors of systemic lupus erythematosus flares during pregnancy.

Luis J Jara1, Gabriela Medina, Pilar Cruz-Dominguez, Carmen Navarro, Olga Vera-Lastra, Miguel A Saavedra.   

Abstract

This review examines the risk factors for the development of systemic lupus erythematosus (SLE) flares during pregnancy. In preconception, anti-DNA, hypocomplementemia, previous thrombosis, triple antiphospholipid (aPL) antibody positivity, active lupus nephritis and discontinuation of medications such as hydroxychloroquine and azathioprine are factors associated with pregnancy failure. During pregnancy, SLE flares are associated with aPL antibodies, synergic changes of pregnancy on Th1 and TH2 cytokines, other cytokines and chemokines that interact with hormones such as estrogen and prolactin that amplify the inflammatory effect. From the clinical point of view, SLE activity at pregnancy onset, thrombocytopenia, lupus nephritis, arterial hypertension, aPL syndromes, preeclampsia is associated with lupus flares and fetal complications. In puerperium, the risk factors of flares are similar to pregnancy. Hyperactivity of immune system, autoantibodies, hyperprolactinemia, active lupus nephritis, decrease in TH2 cytokines with increase in TH1 cytokines probably participate in SLE flare. The SLE flares during pregnancy make the difference between an uncomplicated pregnancy and pregnancy with maternal and fetal complications. Therefore, the knowledge of risk factors leads the best treatment strategies to reduce flares and fetal complications in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391611     DOI: 10.1007/s12026-014-8577-1

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  61 in total

1.  Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy.

Authors:  Miguel A Saavedra; Claudia Cruz-Reyes; Olga Vera-Lastra; Griselda T Romero; Polita Cruz-Cruz; Rafael Arias-Flores; Luis J Jara
Journal:  Clin Rheumatol       Date:  2012-01-27       Impact factor: 2.980

Review 2.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.

Authors:  Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

3.  The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus.

Authors:  Megan E B Clowse; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2011-03-16       Impact factor: 4.666

4.  Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus.

Authors:  N Kobayashi; H Yamada; T Kishida; E H Kato; Y Ebina; N Sakuragi; G Kobashi; A Tsutsumi; S Fujimoto
Journal:  Am J Reprod Immunol       Date:  1999-09       Impact factor: 3.886

5.  The impact of increased lupus activity on obstetric outcomes.

Authors:  Megan E B Clowse; Laurence S Magder; Frank Witter; Michelle Petri
Journal:  Arthritis Rheum       Date:  2005-02

6.  Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.

Authors:  A Leaños-Miranda; G Cárdenas-Mondragón; A Ulloa-Aguirre; I Isordia-Salas; A Parra; J Ramírez-Peredo
Journal:  Lupus       Date:  2007       Impact factor: 2.911

7.  [Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse].

Authors:  Xiu-yan Yang; Liu-qin Liang; Han-shi Xu; Mian He; Shu-zhong Yao; Zhong-ping Zhan; Yu-jin Ye
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2003-09

Review 8.  Autoimmune disease in pregnancy: systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  Jennifer B Warren; Robert M Silver
Journal:  Obstet Gynecol Clin North Am       Date:  2004-06       Impact factor: 2.844

9.  Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus.

Authors:  L Jara-Quezada; A Graef; C Lavalle
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

Review 10.  Challenges of lupus pregnancies.

Authors:  A Doria; A Tincani; M Lockshin
Journal:  Rheumatology (Oxford)       Date:  2008-06       Impact factor: 7.580

View more
  23 in total

1.  Introduction to the special issue on the 9th International Congress on Autoimmunity.

Authors:  Eric Rosenthal; Mathilde Versini; Pierre-Yves Jeandel; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.

Authors:  Bonnie L Bermas; Melissa Tassinari; Megan Clowse; Eliza Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

3.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.

Authors:  Miguel Ángel Saavedra; Antonio Sánchez; Sara Morales; Ulises Ángeles; Luis Javier Jara
Journal:  Clin Rheumatol       Date:  2015-06-07       Impact factor: 2.980

Review 5.  Sexual dimorphism in autoimmunity.

Authors:  Kira Rubtsova; Philippa Marrack; Anatoly V Rubtsov
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

6.  Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.

Authors:  Dongying Chen; Minxi Lao; Xiaoyan Cai; Hao Li; Yanfeng Zhan; Xiaodong Wang; Zhongping Zhan
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

7.  Associations of genetic polymorphisms of TLR5, TLR9 and transduction molecules in MyD88 signaling pathway with systemic lupus erythematosus in Zhuang and Han ethnics of Guangxi province, China.

Authors:  Si-Jian Wen; Fei-Yun Wu; Ling Fang; Hui Liu; Wen-Jun Zheng; You-Kun Lin
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Systemic lupus erythematosus and pregnancy.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

9.  The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes.

Authors:  Matthew Moll; Elizabeth A Regan; John E Hokanson; Sharon M Lutz; Edwin K Silverman; James D Crapo; Barry J Make; Dawn L DeMeo
Journal:  Chronic Obstr Pulm Dis       Date:  2020-04

10.  Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies.

Authors:  Ming Ku; Shuiming Guo; Weifeng Shang; Qing Li; Rui Zeng; Min Han; Shuwang Ge; Gang Xu
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.